Who are we ? - MOBILTEST COVID

A team of collaborators
in search of
innovative solutions

Our mission

Loxamed was born with the ambition to support populations with limited or no access to healthcare and medical care.
The pandemic then struck without warning and Loxamed accelerated its creation to fully invest in the fight against the coronavirus and offer mobile solutions for screening, diagnosis and vaccination.

Mobile health at the heart of our values

Loxamed has developed innovative and connected mobile medical solutions in several major sectors of the daily life of citizens: local authorities (regions, departments, metropolises, communities of agglomerations, municipalities, etc.), transport (in particular with the SNCF and Air France), companies (amusement parks, construction sites, shopping malls, offices, etc.) and sporting or cultural events.

Loxamed extends its interventions to other sectors:

The EHPAD or retirement homes, which see their number of residents with a significant lack of autonomy increase and exceed 90% and their staff decrease, (according to the latest figures of the Drees).

The tourism/hospitality sector, at the heart of the global flow of people, which is being structured in terms of health.

Schools and institutions of higher education that adapted in a hurry during the crisis, but will have to thoroughly review their prevention and protection systems for students once the pandemic is behind us.

Pharmacies, which thanks to Loxamed and its mobile diagnostic and screening boxes, have already been able to benefit from working conditions that meet 100% of sanitary obligations, but which will be subject to reinforced assistance.

Loxamed wins the 2022 Territorial Innovation Award

Loxamed received the Territorial Innovation Award - Territorial Development & Management category - for "the deployment of assisted and connected telemedicine projects, tailored to the problems of medical desertification as well as access to diagnosis and care."

From left to right: Matthieu Guillotin, deputy general manager of Loxamed; Arnaud Molinié, president of Loxamed; Murielle Fabre, general secretary of the Association des Maires de France; and Stéphanie Gay-Torrente, director of the Local Authorities and Real Estate Trade Shows and Conventions division - Infopro Digital. Loxamed

Our
history

From left to right:

A team of collaborators
in search of innovative and tailor-made solutions

Loxamed's team is structured in six main poles. It gathers both experienced profiles and young talents.

A medical department has been created around the doctors of the TeleDok platform, which gathers 100 professionals, emergency physicians, general practitioners, nurses or specialists and which will have the mission to evaluate the good medical practices of the company and to validate the health dimension of the solutions and protocols established by Loxamed.

All the teams of Loxamed work daily to offer to all a simplified access to the care, the screenings and the management.

The executive management team has been able to evolve throughout the crisis as the pandemic has changed. It is highly adaptable and forward-looking.

Arnaud MOLINIÉ

President of Loxamed

Arnaud Molinié is a graduate of the ESJ (École Supérieure de Journalisme) and the École des Hautes Etudes Politiques et Sociales (HEPS) in Paris. He began his career as a journalist at the Nouvelles de Versailles, then as a researcher at the S.I.G (Service d'Information du Gouvernement) before joining the general management of Lyonnaise des Eaux.

In 1998, he became Director of Communications for Genopole (the French government's genetics program), which he left in 2000 to join the Lagardère Group, where he successively held the positions of Director of Communications, Director of Strategy and Development, Managing Director of various activities and CEO of various subsidiaries, including Lagardère Entertainment, which he created in 2007.

He joined Deloitte in 2015, first as a senior advisor and then as a partner until December 2018.

He joins the Renault Group in January 2019 as Global Mobility Director and then as Senior Vice President and General Manager of Renault M.A.I (Mobility As an Industry).

In May 2020, Arnaud Molinié left Renault to create LOXAMED with Gérard Deprez, President of LOXAM, Frédéric Lefebvre, and Éric Sebban, President of AXAMED laboratories, of which he became President.

Finally, Arnaud Molinié has been a volunteer for 15 years with the Association Française contre les Myopathies (AFM) through the Telethon. Founder of the Voix du Téléthon, host of the Téléthon des Financiers, he was an administrator of the AFM and deputy treasurer of this association.

Matthieu Guillotin

Chief Operating Officer

Matthieu Guillotin started his career in Asia at Alcatel-Lucent in business development. He then joined the Renault Group, where he was able to work in all areas of marketing and actively contribute to the development of the Group's new Mobility strategy as Executive Secretary to the Senior Vice-President for New Mobility and Electric Vehicles.

With an ear for trends and a strong focus on innovation, he will join Loxamed in November 2020 to grow our company's offering and footprint.

Matthieu Guillotin holds a Master's degree in International Business from the University of Paris Dauphine and an engineering degree from ESIEA.

Cédric Lacour

Sales Manager

He has worked for the Renault Group for 24 years in various positions of responsibility. He was marketing director in Tehran, marketing manager in South America, and in 2014 he became director of electric vehicles in Europe.

In 2019, he was appointed Director of New Mobility Business Development.

He is specialized in the development and deployment of commercial strategies, the animation of commercial networks and the launch of new products. He joins Loxamed as sales manager.

Sabrina Del-Monte

Director of Operations

A business school graduate, she is specialized in supply chain management. After graduating in 2010, she became project manager at Coca-Cola before joining Etam in 2012.

She started as an export commercial logistics manager, then between 2014 and 2017 she held the positions of commercial management manager and supply chain project manager, before becoming the group's international supply chain operations manager in 2017.

After 10 years spent at Etam, Sabrina Del Monte joined Loxamed as Operations Manager, in charge of the company's logistic follow-up.

François Teboul / Teledok

Medical Director

Teledok is a tele-medical platform that brings together, under the direction of Dr. François Teboul, a team of general practitioners and emergency physicians who practice tele-consultation and conduct research on tele-medicine.

They have been partners of Loxamed since the creation of the company and will now be in charge of the medical direction.

Their mission will be to validate the sanitary dimension of the solutions and protocols proposed by Loxamed.

Grégoire Bolloré

Financial Director

Grégoire Bolloré obtained his Master's degree in Management Sciences from ESSEC Business School, where he studied for 5 years and where he was Vice-Treasurer of the Junior ESSEC Conseil Association.

After graduating from ESSEC, Grégoire began his career in financial consulting at Eight Advisory where he was in charge of M&A transactions.

He then joined Loxamed as CFO of the company.

Arnaud Carroué

Director of Communications

Graduate of the French Press Institute (University of Paris - Panthéon Assas).

After having been in charge of communications at the Europe 1 press office and then at the TV viewer relations and public relations department of M6, he became editor-in-chief of the Mediabarre.com website.

In 2001, he joined the Lagardère Group's Communications Department as an editor. In 2008, he was appointed Head of Internal Communications. Editor-in-chief of the Group's internal newspaper, he is also responsible for the Lagardere.com website, the Group's internal portal and the Lagardère Ressources intranet. In 2019, he was also appointed head of the Lagardère Group's Images division.

Pascal Brun

Senior Advisor Hospitality

Pascal Brun is one of the most respected professionals in the hotel and restaurant business. He was General Manager-Côte d'Azur of the Barrière Group for 13 years before becoming Vice President of Operations of the Mauritian hotel group Sun resorts.

He then became Chairman and CEO of the Frères Blanc group and has now created his own hotel consulting company Valentoria, specializing in hotel management and administration.

He joins Loxamed as a Senior Advisor to help us develop and adapt our solutions for the tourism industry.

Our latest publications

Strengthen your health care system for the summer period

Loxamed accompanies you in the installation of prevention and telemedicine devices in boxes, mobile medical vehicles, or in places made available by the municipality.

View PDF
Promoting prevention and health in the workplace

In an environment exposed to health risks and marked by difficulties of access to care, the company has a key role to play with its employees. Whether it is awareness raising, screening, vaccination or teleconsultation, Loxamed develops systems that mobilize its medical department and its network of partners (health professionals, laboratories...).

View PDF
Fighting against medical deserts, serving local authorities

Loxamed accompanies the territories in the different stages of the implementation of a medical project. From consulting to implementation, Loxamed has developed an approach of organization and territorial health cooperation that facilitates and improves the health pathway of people with difficulties in access to care. Loxamed integrates and brings together all the stakeholders of the ecosystem: health professionals (in particular via the CPTS), local authorities, ARS, DCGDR, Health Insurance Funds...

View PDF
Vaccination in the workplace - January 2023 brochure

Based on our experience and know-how in periods of epidemic peaks, we can offer you customized epidemic, we offer customized solutions, mobile or in situ, for vaccination against Covid-19 and/or influenza to improve the protection of your employees.

View PDF
Mobility, telemedicine, advocacy for health in the ^21st century

This book brings together numerous contributions from health and political actors, as well as from members of civil society. Essential testimonies and valuable experiences to feed the framework of tomorrow's public health policy. Enriched with a first part that gives the main benchmarks of the healthcare offer in France and internationally, this white paper also includes an exclusive survey on "The French and equal access to healthcare".

View PDF
Brochure: Fighting against medical deserts, including in white areas

Fight against medical deserts including in white zone Loxamed accompanies the territories in the different stages of the implementation of a medical project. From consulting to implementation, Loxamed has developed an approach of organization and territorial health cooperation that facilitates and improves the health pathway of people with difficulties in access to care. Loxamed integrates and brings together all the stakeholders of the ecosystem: health professionals and territorial organizations such as CPTS, elected officials, the Region, EPCI, Departmental Councils, ARS, DCGDR and Health Insurance Funds.

View PDF
Loxamed offers a fast conversion service of the vaccination pass to European standards, for French people living abroad

For any person having validated a complete vaccination course outside a country delivering vaccination certificates in European format, Loxamed proposes a service of conversion of the original vaccination pass in European pass. This equivalence is even mandatory for residents of many countries1. In order to be authorized to enter the French territory and in the majority of European countries, the French from abroad must now obtain an equivalence of the European pass.

View PDF
A screening device installed in the Westfield Parly 2 shopping center in Chesnay-Rocquencourt

In this period of record epidemic resurgence, the city of Le Chesnay-Rocquencourt has made every effort to ensure the safety of its citizens and visitors to the Westfield Parly 2 shopping center, located in the commune. In partnership with Loxamed and Cerballiance laboratories, and with the financial support of the Ile-de-France region, the city decided to install an RT-PCR screening system in the heart of the Westfield Parly 2 shopping center, which receives more than 12 million visits per year.

View PDF
A mobile screening box installed in Versailles

In a context of intense spread of the virus and in order to meet the high demand for testing, the city of Versailles has called upon Loxamed to deploy a mobile and operational covid test device, in the heart of the city and for all citizens.

View PDF
Loxamed supports ski resorts and installs a COVID screening device in Chamrousse

Loxamed installs a screening device in the heart of the Chamrousse ski resort and reinforces the sanitary means of the municipality in this period of great tourist attraction. In a context of strong pandemic recrudescence, ski resorts are getting ready to enter the most touristic period of the year. They are facing the need to reinforce their medical tools in order to respond to the very high demand for screening.

View PDF
Loxamed installs a sanitary hub in Louveciennes

Loxamed, a company specialized in mobility and medical technology, has developed a Health Hub with the city of Louveciennes. Within this Hub, health professionals intervene to offer RT-PCR tests, antigenic tests and teleconsultation. Loxamed also supports pharmacies in the framework of the vaccination campaign and with the help of the city council.

View PDF
LOXAMED FLAG BEARER OF MEDICAL INNOVATION AT THE SALON DES MAIRES

Loxamed, a company specialized in mobility and medical technology, will participate in the Salon des Maires, from November 16 to 18, 2021. A stand dedicated to the company will be installed in pavilion 2.2. The issues related to health in the territories will be placed at the heart of the show. The health inequalities revealed during the pandemic, the issue of medical deserts and access to care, are essential and urgent challenges for municipalities and communities.

View PDF
Loxamed, in strong growth, is strengthening and structuring itself to face the new health challenges that are coming.

Loxamed, a company specializing in medical mobility, has been present since the beginning of the health crisis by deploying high-performance screening and telemedicine solutions throughout the country, in train stations, stadiums, amusement parks, local authorities and businesses, in the form of mobile boxes, travelling trucks or solid installations.

View PDF
As part of the implementation of the health pass in transport, Loxamed is installed in 11 new stations and offers travelers a rapid screening solution

Since Monday, August 9, Loxamed is present in 11 new train stations including Metz Ville, Nancy, Paris Montparnasse 1 and 2, Strasbourg, Le Mans, Toulouse and offers Covid antigenic screening to further secure the populations during the summer period and to facilitate the implementation of the health pass in transport.

View PDF
THE ASTERIX PARK, IN PARTNERSHIP WITH LOXAMED, PROVIDES ITS VISITORS WITH A RAPID SCREENING DEVICE AT THE PARK ENTRANCE

Following the declarations of the President of the Republic on July 12, announcing the implementation of the health pass in the places of leisure and culture, the Asterix park (Oise), in partnership with LOXAMED, decided to install, at the entrance of the park and from July 21, 2021, a specific screening device, having for objective to secure and facilitate the access to the park of the future visitors

View PDF
REOPENING OF NIGHTCLUBS: LOXAMED INSTALLS IN LA BAULE-ESCOUBLAC THE FIRST COVID SCREENING BOX IN THE LOIRE ATLANTIQUE

In collaboration with the city of La Baule and as an extension of its national partnership with SNCF Gares & Connexions, Loxamed is installing an RT-PCR screening box in front of the La Baule-Escoublac train station for summer vacationers, especially young people.

View PDF
LOXAMED is structured to meet the health challenges of the tourism industry

Loxamed is recruiting a senior advisor recognized in the fields of hotel and commercial catering to accompany it in the development and adaptation of its solutions to the service of the tourist industry.

View PDF
Loxamed, with its partner Unilabs France, installs a unique immediate screening device for Air France flight crews

Loxamed has built for its client Air France a fully adapted RT-PCR screening device, in partnership with Unilabs France laboratories.

View PDF
In partnership with SNCF Gares & Connexions, Loxamed and Unilabs France laboratories are installing the first "Mobiltest" saliva screening box on the forecourt of the Gare Saint-Lazare

After Paris Gare de Lyon, the stations of Paris-Est, Marseille Saint-Charles, Bordeaux Saint-Jean, Nice Ville, Rennes and Grenoble, Loxamed has moved to the Havre square of the Gare Saint-Lazare to to contribute to the screening capacities in Paris and to experiment with saliva sampling with its partner Unilabs France.

View PDF
In partnership with SNCF Gares&Connexions and the city of Nice, Loxamed installs a vaccination box against COVID-19 on the forecourt of the Nice-City station

After installing a screening BOX on the square in front of the Nice Ville train station on March 1 to facilitate access to tests, Loxamed is now deploying a "MobilVaccin" BOX on the same square to reinforce the vaccination capacities of the Nice Côte d'Azur metropolis.

View PDF
Covid-19 has created a mobile medical solution adapted to medical deserts

Loxamed, a company specialized in medical mobility, is fully committed since the beginning of the pandemic, in the national policy of health security, with in particular for leitmotiv the accompaniment of the isolated territories, having at their disposal a saturated or even non-existent medical offer.

View PDF
Loxamed expands its activities on a European scale by becoming a player in the Belgian vaccinodromes

Since the beginning of February, Loxamed has installed modular boxes in 5 vaccinodromes in Belgium in order to participate more widely in the fight against Covid-19.

View PDF
Loxamed ensures once again the sanitary security of the Six Nations Tournament!

Loxamed is the health partner of the French Rubgy Federation since the beginning of the health crisis. It ensures the safety of the events and of the women and men teams in front of the Covid.

View PDF
LOXAMED expands and structures to meet new health challenges

To cope with the influx of screening requests, to be present during the vaccination phase and to anticipate tomorrow's changes, Arnaud Molinié, President of LOXAMED, in agreement with Gérard Deprez, President of Loxam, has decided to further strengthen and structure LOXAMED's executive team by appointing Matthieu Guillotin, sales director and mobility expert. Olivier Falque, a Loxam employee for nearly 20 years, is also joining the LOXAMED teams to bring his expertise in logistics as Operations Manager.

View PDF
The town hall of l'Etang-la-Ville, in partnership with the Ile-de-France Region and Loxamed, installs a MobilTest box for COVID-19 screening

The city hall of Etang-la-Ville, as part of the great screening campaign initiated by the Ile-de-France Region, intensifies its participation in the national effort by opening to all Stagnovillois and inhabitants of the surrounding towns, a MobilTest Loxamed box on Monday, November 23, in the Val d'Argent market place.

View PDF
LOXAMED, IN PARTNERSHIP WITH SNCF GARES & CONNEXIONS AND THE CITY OF RENNES, INSTALLS A "MOBILTEST" SCREENING BOX FOR COVID-19 ON THE SOUTH SQUARE OF RENNES STATION

In order to strengthen the national COVID-19 screening mobilization, SNCF Gares & Connexions has responded favorably to Loxamed, a medical mobility company, for the installation of 5 booths on station forecourts. After Paris Gare de Lyon and the stations of Paris-Est, Marseille Saint-Charles and Bordeaux Saint-Jean, a mobile COVID screening unit is now opening on the southern forecourt of Rennes station.

View PDF
Press conference. Presentation of the innovative Mobiltest device

In order to reinforce the national screening mobilization of COVID-19, SNCF Gares & Connexions has responded favorably to Loxamed, a medical mobility company, for the installation of five screening units on the forecourts of several stations. After two Paris stations on November 5, mobile COVID screening units will open this Thursday, November 12, on the forecourts of Marseille Saint-Charles and Bordeaux Saint-Jean stations.

View PDF
LOXAMED, IN PARTNERSHIP WITH SNCF GARES & CONNEXIONS, INSTALLS A "MOBILTEST" BOX FOR COVID-19 SCREENING ON THE FORECOURT OF THE MARSEILLE SAINT - CHARLES STATION

In order to strengthen the national COVID-19 screening campaign, SNCF Gares & Connexions has responded favorably to Loxamed, a medical mobility company, for the installation of 5 booths on station forecourts. Mobile COVID screening units are opening today on the forecourts of Marseille Saint-Charles and Bordeaux Saint-Jean stations, following the deployment of the first two booths in front of Paris Gare de Lyon and Paris-Est stations on November 5. A fifth booth will soon be installed in front of the Rennes station.

View PDF
LOXAMED, IN PARTNERSHIP WITH SNCF GARES & CONNEXIONS, INSTALLS A "MOBILTEST" BOX FOR COVID-19 SCREENING ON THE FORECOURT OF BORDEAUX SAINT-JEAN STATION

In order to strengthen the national COVID-19 screening mobilization, SNCF Gares & Connexions has responded favorably to Loxamed, a medical mobility company, for the installation of 5 booths on station forecourts. Mobile COVID screening units are opening today on the forecourts of Bordeaux Saint-Jean and Marseille Saint-Charles stations, following the deployment of the first two booths in front of Paris Gare de Lyon and Paris-Est stations on November 5. A fifth booth will soon be installed in front of the Rennes station.

View PDF
LOXAMED, IN PARTNERSHIP WITH SNCF GARES & CONNEXIONS, INSTALLS "MOBILTEST" SCREENING BOXES FOR COVID-19 IN FIVE STATION FORECOURTS

To reinforce the national screening campaign for COVID-19, SNCF Gares & Connexions has responded favorably to Loxamed, a medical mobility company, for the installation of 5 booths on station forecourts. Mobile COVID screening units will be installed on November 5 in front of Paris Gare de Lyon and Paris East stations. Very soon, the forecourts of the Marseille Saint-Charles and Bordeaux Saint-Jean stations, and then Rennes, will also be equipped with screening booths.

View PDF
Loxamed is proud to announce that it is installing the first on-board diagnostic and screening unit on the "We love 2023" train built by the SNCF for the upcoming Rugby World Cup in France.

On the occasion of the inauguration of the train "We love 2023", deployed by the SNCF for the Rugby World Cup 2023, Loxamed presented its Covid test and diagnostic unit that will be installed in one of the train's cars. During the visit of the train, the Mayor of Paris, Anne Hidalgo underlined During the visit of the train, the Mayor of Paris, Anne Hidalgo, underlined "the efficiency of the Loxamed device", which she tested in Paris in the 19th district, in the context of screening migrant workers.

View PDF
Loxamed is proud to actively participate in the reinforcement of the screening means of the Ile-de-France region by the deployment of two mobile screening trucks, MobilTests, which will criss-cross the entire Ile-de-France territory.

Loxamed has been chosen by the Ile-de-France region to reinforce its screening policy and make it accessible to all Ile-de-France residents. The Ile-de-France region is facing a deterioration of its health situation in its eight departments. An efficient screening policy is an essential means to contain the circulation and spread of the virus.

View PDF
COVID-19: THE ILE-DE-FRANCE REGIONAL HEALTH AGENCY VALIDATES THE LOXAMED SANITARY PROTOCOL

As new outbreaks of contamination are leading to fears of a resumption of the COVID-19 epidemic, the Ile-de-France Regional Health Agency (ARS) has just issued a favorable opinion on LOXAMED's Mobile Diagnostic and Screening Unit, which will reinforce the control and fight against the epidemic.

View PDF
The OL presents its return to activity and the "OL PROTEGE" system

Olympique Lyonnais informs that it will resume its activity on Monday, June 8, which will be done within a very strict sanitary framework and in the respect of the protection of the health of the employees which is an absolute priority. The epidemic remains active and the virus is still circulating; it is everyone's responsibility to remain cautious and respect all barrier measures.

View PDF
COVID-19: A PILOT OF MOBILE DIAGNOSTIC AND SCREENING UNITS IS LAUNCHED IN PARIS IN THE 19th DISTRICT TO ASSIST THE DECOUNTING PHASE

For more than 15 days, a pilot mobile diagnostic and screening unit (UMDD) has been installed in front of a migrant workers' hostel in the 19th arrondissement. This innovative device, designed by the LOXAM company, in partnership with the AXAMED laboratories and the TELEDOK medical platform, will be deployed, at the request of the City of Paris, in all of the capital's districts in order to meet the needs of the city and its inhabitants during the decontamination period.

View PDF